Kin-Ming Lo
Impact in
- Immunology and Allergy top 2%
- Cell Adhesion Molecules Research
- Immunology top 2%
- Immunotherapy and Immune Responses
Papers in
-
- Cell Adhesion Molecules Research 8
-
- Monoclonal and Polyclonal Antibodies Research 18
- Co-authors
- Kashi JavaherianJudah FolkmanStephen D. GilliesGabriele BergersDouglas HanahanYan LanKaren S. MoultonKhashayar Vakili
- Journals
- Protein Engineering Design and Selection (4 papers)Proceedings of the National Academy of Sciences (4 papers)Cancer Research (4 papers)Clinical Cancer Research (3 papers)Cancer Immunology Immunotherapy (2 papers)
- Partner nations
- United StatesItalyGermany
In The Last Decade
Kin-Ming Lo
42 papers receiving 3.4k citations
Hit Papers
Peers
Comparison fields: 5 of 108
- Immunology and Allergy 336
- Immunology 1.1k
- Oncology 1.4k
- Cancer Research 688
- Radiology, Nuclear Medicine and Imaging 789
Countries citing papers authored by Kin-Ming Lo
This map shows the geographic impact of Kin-Ming Lo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kin-Ming Lo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kin-Ming Lo more than expected).
Fields of papers citing papers by Kin-Ming Lo
This network shows the impact of papers produced by Kin-Ming Lo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kin-Ming Lo. The network helps show where Kin-Ming Lo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kin-Ming Lo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 12 | |
| 2 | Enhanced preclinical antitumor activity of M7824, a bifunctional fusion protein simultaneously targeting PD-L1 and TGF-β Hit paper breakdown → | 2018 | 405 |
| 3 | 2017 | 58 | |
| 4 | 2014 | 47 | |
| 5 | 2011 | 77 | |
| 6 | 2010 | 153 | |
| 7 | Improved pharmacokinetics and efficacy of endostatin by fusion with IgG Fc domain | 2007 | 1 |
| 8 | 2006 | 49 | |
| 9 | 2005 | 28 | |
| 10 | 2005 | 77 | |
| 11 | 2005 | 27 | |
| 12 | HuBC1-IL12: A very potent immunocytokine which targets the oncofetal fibronectin in the extracellular matrix of tumor vasculature | 2004 | 1 |
| 13 | Engineering of an IL-2 immunocytokine with very low toxicity that retains potent anti-tumor activity in immune competent and immune deficient mouse tumor models | 2004 | 2 |
| 14 | 2004 | 32 | |
| 15 | 2002 | 40 | |
| 16 | 2001 | 64 | |
| 17 | Improving the efficacy of antibody-interleukin 2 fusion proteins by reducing their interaction with Fc receptors. | 1999 | 37 |
| 18 | 1998 | 69 | |
| 19 | 1998 | 78 | |
| 20 | 1985 | 7 |
About Kin-Ming Lo
Kin-Ming Lo is a scholar working on Immunology and Allergy, Radiology, Nuclear Medicine and Imaging, Immunology, Oncology and Biotechnology, having authored 43 papers that have together received 3.5k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (18 papers), Glycosylation and Glycoproteins Research (11 papers), Angiogenesis and VEGF in Cancer (9 papers), Immunotherapy and Immune Responses (8 papers), Cell Adhesion Molecules Research (8 papers), Cancer Immunotherapy and Biomarkers (5 papers), Cancer Research and Treatments (4 papers) and CAR-T cell therapy research (4 papers). The work is most often cited by research in Immunology and Allergy (336 citations), Immunology (1.1k citations), Oncology (1.4k citations), Cancer Research (688 citations) and Radiology, Nuclear Medicine and Imaging (789 citations). Kin-Ming Lo has collaborated with scholars based in United States, Italy and Germany. Frequent co-authors include Kashi Javaherian, Judah Folkman, Stephen D. Gillies, Gabriele Bergers, Douglas Hanahan, Yan Lan, Karen S. Moulton, Khashayar Vakili, David Zurakowski and Catherine Butterfield. Their work appears in journals such as Protein Engineering Design and Selection, Proceedings of the National Academy of Sciences, Cancer Research, Clinical Cancer Research and Cancer Immunology Immunotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.